InsiderClue
Insiders · Profile

Davis Todd C

Director at Pelthos Therapeutics · Chief Executive Officer at LIGAND PHARMACEUTICALS. Filing since 10 Aug 2011. CIK 0001392029

PTHS Pelthos Therapeutics Inc. Director · 1 trade LGND LIGAND PHARMACEUTICALS INC Chief Executive Officer · 13 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PTHS Pelthos Therapeutics Inc.
11 Jun 2026
Director
Bought
35,948
$999.98K
90.1%
LGND LIGAND PHARMACEUTICALS INC
9 May 2025
Chief Executive Officer
Bought
9,510
$1.00M
6.3%
LGND LIGAND PHARMACEUTICALS INC
8 Aug 2024
Chief Executive Officer
Bought
2,500
$243.48K
2.1%
LGND LIGAND PHARMACEUTICALS INC
22 Sep 2023
CHIEF EXECUTIVE OFFICER
Bought
4,000
$237.53K
5.8%
LGND LIGAND PHARMACEUTICALS INC
10 Feb 2021
Director
Sold, plan not stated
5,083
$1.08M
9.6%
LGND LIGAND PHARMACEUTICALS INC
2 Aug 2019
Director
Bought
1,000
$93.59K
2.1%
LGND LIGAND PHARMACEUTICALS INC
8 Oct 2018
Director
Sold, plan not stated
2,500
$634.98K
5.5%
LGND LIGAND PHARMACEUTICALS INC
17 Aug 2018
Director
Sold, plan not stated
3,167
$758.50K
6.6%
LGND LIGAND PHARMACEUTICALS INC
16 Aug 2018
Director
Sold, plan not stated
5,833
$1.40M
10.8%
LGND LIGAND PHARMACEUTICALS INC
27 Feb 2018
Director
Sold, plan not stated
12,335
$1.87M
18.7%
LGND LIGAND PHARMACEUTICALS INC
26 Feb 2018
Director
Sold, plan not stated
4,835
$742.54K
6.8%
LGND LIGAND PHARMACEUTICALS INC
19 Mar 2014
Director
Sold, plan not stated
5,000
$398.15K
13.3%
LGND LIGAND PHARMACEUTICALS INC
18 Mar 2014
Director
Sold, plan not stated
2,500
$198.64K
6.2%
LGND LIGAND PHARMACEUTICALS INC
10 Aug 2011
Director
Bought
15,000
$163.50K
106%
14 decisions on file.